Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Syndax
3184
Syndax
Technology
Biotechnology
Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
Suggest edits
Founded
2005
Raised
$40.5M
Follow us
Companies in the same industry
Milestone Pharmaceuticals, Inc.
Westway Health
NGXBio
Apic Bio
LifeMine Therapeutics
Xerion Healthcare
4D Molecular Therapeutics
Spartan Bioscience
Nymirum
Hemex Health
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$4,947,480
Debt financing - 2014
$26,600,000
Venture capital (Series B) - 2013
Domain Associates
MPM Capital
RusnanoMedInvest
+1
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
Xconomy
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More
Health
Stock markets
